Should HIV treatment start right away? new study tests timing

NCT ID NCT03825523

First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study looked at whether starting antiretroviral therapy (ART) immediately (within 48 hours) versus waiting until an opportunistic infection is under control affects death rates in HIV/AIDS patients hospitalized with such infections. Researchers enrolled 114 adults with HIV and an opportunistic disease. The goal was to see if immediate treatment saves more lives.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
antiretroviral therapy (ART)
What this could lead to
If immediate ART works better, it could lead to a standard practice of starting HIV treatment right away in hospitalized patients with opportunistic infections, potentially saving more lives.
What could go wrong
This is a small completed study (114 participants) and results may not apply to all HIV patients, especially those with certain infections like cryptococcal meningitis. Timing of ART is just one factor in a complex disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIDS-RELATED MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centro de Investigacion en Enfermedades Infecciosas

    México, State of Mexico, 14080, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.